overall survival

Open Access
Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG, NAN YOUNG LEE, IN HEE LEE, JI YOUNG PARK and DAE GY HONG

In Vivo July 2022, 36 (4) 1903-1910; DOI: https://doi.org/10.21873/invivo.12910
You have access
Docetaxel Rechallenge Improves Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study
SHENG-CHUN HUNG, LI-WEN CHANG, JIAN-RI LI, SHIAN-SHIANG WANG, CHENG-KUANG YANG, CHUAN-SHU CHEN, KEVIN LU, CHENG-CHE CHEN, SHU-CHI WANG, CHIA-YEN LIN, CHEN-LI CHENG, YEN-CHUAN OU and KUN-YUAN CHIU

In Vivo November 2021, 35 (6) 3509-3519; DOI: https://doi.org/10.21873/invivo.12653
You have access
Association Between Renal Adverse Effects and Mortality in Patients With Hepatocellular Carcinoma Treated With Lenvatinib
YOSHINOSUKE SHIMAMURA, KOKI ABE, TAKUTO MAEDA, TAKESHI MATSUI, ATSUSHI ISHIGURO and HIDEKI TAKIZAWA

In Vivo May 2021, 35 (3) 1647-1653; DOI: https://doi.org/10.21873/invivo.12423
You have access
Systemic Review and Meta-analysis of Impact of Splenectomy for Advanced Gastric Cancer
CHIKARA KUNISAKI, SHO SATO, NOBUHIRO TSUCHIYA, JUN WATANABE, TSUTOMU SATO, KAZUHISA TAKEDA, KOHEI KASAHARA, TAKASHI KOSAKA, HIROTOSHI AKIYAMA, ITARU ENDO and TOSHIHIRO MISUMI

In Vivo November 2020, 34 (6) 3115-3125; DOI: https://doi.org/10.21873/invivo.12145
You have access
Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer
IVETA KOLAROVA, LADISLAV DUSEK, ALES RYSKA, KAREK ODRAZKA, MARTIN DOLEZEL, JAROSLAV VANASEK, BOHUSLAV MELICHAR, JIRI PETERA, TOMAS BUCHLER, MILAN VOSMIK, KATARINA PETRAKOVA, PETRA TERAROVA, ZDENA VILASOVA and JIRI JARKOVSKY

In Vivo November 2020, 34 (6) 3441-3449; DOI: https://doi.org/10.21873/invivo.12183
You have access
Anatomical Versus Non-anatomical Resection for Hepatocellular Carcinoma, a Propensity-matched Analysis Between Taiwanese and Japanese Patients
SHIH-WEI HUANG, PEI-YI CHU, SHUNICHI ARIIZUMI, CHARLES CHUNG-WEI LIN, HON PHIN WONG, DEV-AUR CHOU, MING-TSUNG LEE, HSING-JU WU and MASAKAZU YAMAMOTO

In Vivo September 2020, 34 (5) 2607-2612; DOI: https://doi.org/10.21873/invivo.12078
You have access
Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma
KAZUO KOBAYASHI, YUSUKE IIKURA, MAKOTO HIRAIDE, TAKASHI YOKOKAWA, TAKESHI AOYAMA, SARI SHIKIBU, KOKI HASHIMOTO, KENICHI SUZUKI, HITOSHI SATO, ERIKA SUGIYAMA, MASATAKA TAJIMA and TOSHIHIRO HAMA

In Vivo September 2020, 34 (5) 2647-2652; DOI: https://doi.org/10.21873/invivo.12083
You have access
Elderly Patients With Single Brain Metastasis – Overall Survival After Surgery Plus Whole-Brain Irradiation and a Radiation Boost
DIRK RADES, TRANG NGUYEN and STEVEN E. SCHILD

In Vivo May 2020, 34 (3) 1421-1425; DOI: https://doi.org/10.21873/invivo.11923
You have access
Interval Between Cancer Diagnosis and Radiotherapy – An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer
DIRK RADES, RAPHA HAUS, STEFAN JANSSEN and STEVEN E. SCHILD

In Vivo March 2020, 34 (2) 767-770; DOI: https://doi.org/10.21873/invivo.11836
You have access
Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin
CHIKAGE NARUI, HIROSHI TANABE, JASON S. SHAPIRO, YOKO NAGAYOSHI, TAKENORI MARUTA, MOMOKO INOUE, YUKIHIRO HIRATA, HIROMI KOMAZAKI, HIROKUNI TAKANO, SHIGEKI NIIMI, SEIJI ISONISHI and AIKOU OKAMOTO

In Vivo November 2019, 33 (6) 2045-2050; DOI: https://doi.org/10.21873/invivo.11702

Main menu

User menu

Search

overall survival

Pages